Commit Closes 60 Million Seed for Complement Engagers

Company Commit Biologics Event Type Seed financing final close ($60 million) Modality Bispecific complement engager Asset COM002 Target C1q engagement (antigen undisclosed) Disease Area Cancer and autoimmunity Summary Commit Biologics, an Aarhus University spinout, announced final close of a $60 million (€54 million) seed financing…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *